| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TRIM46 TPM4 FKBP15 MYH6 MYH11 HDAC6 PACSIN1 CETN1 SYNE1 NUMA1 VASH1 CKAP5 AIF1L ACTN1 TTLL7 BICD1 SYNE3 PPP5C ARHGEF10 MACO1 FHOD1 TLN1 PHACTR3 KIF14 TLN2 DIXDC1 RP1 | 1.83e-07 | 1099 | 160 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | TPM4 FKBP15 MYH6 MYH11 HDAC6 SYNE1 VASH1 AIF1L ACTN1 SYNE3 FHOD1 TLN1 PHACTR3 TLN2 DIXDC1 | 7.49e-06 | 479 | 160 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | actin filament binding | 1.52e-05 | 227 | 160 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | dynein complex binding | 7.00e-05 | 28 | 160 | 4 | GO:0070840 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | TRIM46 HDAC6 COPG1 SYNE1 NUMA1 LMNB2 AP3B1 CBL BICD1 SNAP29 SYNE3 FHOD1 AP3B2 SYK KIF14 UNC13C | 5.66e-06 | 546 | 160 | 16 | GO:0051656 |
| GeneOntologyBiologicalProcess | actin filament-based process | TPM4 MYH6 MYH11 HDAC6 FGD2 PACSIN1 ARHGAP26 ARHGAP17 AIF1L ACTN1 RYR2 ARHGEF10L GPD1L LIMK1 ARHGEF10 FHOD1 TLN1 PHACTR3 SCN7A TLN2 DIXDC1 | 8.11e-06 | 912 | 160 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | intracellular transport | TRIM46 HDAC6 UACA COPG1 VPS45 SYNE1 ENTR1 SNX17 NUMA1 SRPRA HEATR5A ICE1 LMNB2 VPS26A NUP58 AP3B1 THOC2 YWHAE BICD1 AP2M1 SYNE3 CTAGE1 FHOD1 AP3B2 SYK LRP6 EEA1 VPS53 | 1.16e-05 | 1496 | 160 | 28 | GO:0046907 |
| GeneOntologyBiologicalProcess | organelle localization | TRIM46 HDAC6 COPG1 SYNE1 NUMA1 LMNB2 AP3B1 CBL BICD1 SNAP29 SYNE3 KCNB1 FHOD1 AP3B2 SYK KIF14 UNC13C | 3.42e-05 | 703 | 160 | 17 | GO:0051640 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | TPM4 MYH6 MYH11 HDAC6 FGD2 PACSIN1 ARHGAP26 ARHGAP17 AIF1L ACTN1 ARHGEF10L LIMK1 ARHGEF10 FHOD1 TLN1 PHACTR3 TLN2 DIXDC1 | 5.35e-05 | 803 | 160 | 18 | GO:0030036 |
| GeneOntologyBiologicalProcess | microtubule-based process | TRIM46 DNAH3 HDAC6 COPG1 CETN1 CNTRL NUMA1 CKAP5 AP3B1 LDHC TTLL7 BICD1 FSIP2 ARHGEF10 RP1L1 AP3B2 KIF14 CEP152 DIXDC1 RP1 CCDC40 | 7.19e-05 | 1058 | 160 | 21 | GO:0007017 |
| GeneOntologyBiologicalProcess | organelle transport along microtubule | 1.10e-04 | 97 | 160 | 6 | GO:0072384 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | HK2 UACA SYNE1 ENTR1 NUMA1 SRPRA LMNB2 NUP58 AP3B1 CBL MEAK7 YWHAE RYR2 BICD1 FSIP2 CDK5RAP3 ATP6V1D SYK CPLANE1 VPS53 CCDC40 | 1.11e-04 | 1091 | 160 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | nuclear migration | 1.35e-04 | 34 | 160 | 4 | GO:0007097 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.40e-04 | 145 | 160 | 7 | GO:0001578 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TRIM46 HDAC6 CETN1 CNTRL NUMA1 CKAP5 TTLL7 BICD1 FSIP2 ARHGEF10 RP1L1 KIF14 CEP152 DIXDC1 RP1 CCDC40 | 1.57e-04 | 720 | 160 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis | 1.73e-04 | 67 | 160 | 5 | GO:0048260 | |
| GeneOntologyBiologicalProcess | beta selection | 1.78e-04 | 3 | 160 | 2 | GO:0043366 | |
| GeneOntologyCellularComponent | cytoplasmic region | TRIM46 DNAH3 HDAC6 CNTRL NUMA1 CKAP5 AP3B1 RP1L1 AP3B2 UNC13C RP1 CCDC40 | 2.68e-05 | 360 | 163 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.94e-04 | 107 | 163 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.94e-04 | 107 | 163 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.99e-04 | 317 | 163 | 10 | GO:0032838 | |
| GeneOntologyCellularComponent | actomyosin | 3.14e-04 | 117 | 163 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 3.29e-04 | 118 | 163 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | cilium | DNAH3 HDAC6 CETN1 ENTR1 CNTRL CBL LDHC TTLL7 SNAP29 FSIP2 VCAN ATP6V1D RP1L1 PKM RP1 CPLANE1 CCDC40 | 6.66e-04 | 898 | 163 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | cell-substrate junction | TPM4 COL17A1 ARHGAP26 AIF1L ACTN1 CBL YWHAE LIMK1 TLN1 TLN2 DIXDC1 | 7.34e-04 | 443 | 163 | 11 | GO:0030055 |
| GeneOntologyCellularComponent | exosome (RNase complex) | 8.35e-04 | 24 | 163 | 3 | GO:0000178 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic vesicle membrane | 9.44e-04 | 25 | 163 | 3 | GO:0098850 | |
| Domain | Clathrin/coatomer_adapt-like_N | 6.26e-06 | 15 | 158 | 4 | IPR002553 | |
| Domain | Adaptin_N | 6.26e-06 | 15 | 158 | 4 | PF01602 | |
| Domain | AP3_beta | 7.11e-05 | 2 | 158 | 2 | IPR026740 | |
| Domain | - | 7.11e-05 | 2 | 158 | 2 | 1.20.1420.10 | |
| Domain | - | 7.11e-05 | 2 | 158 | 2 | 1.10.930.10 | |
| Domain | Kinase_SYK/ZAP-70_inter-SH2 | 7.11e-05 | 2 | 158 | 2 | IPR023420 | |
| Domain | AP3B_C | 7.11e-05 | 2 | 158 | 2 | IPR029390 | |
| Domain | VBS | 7.11e-05 | 2 | 158 | 2 | PF08913 | |
| Domain | AP3B1_C | 7.11e-05 | 2 | 158 | 2 | PF14796 | |
| Domain | Vinculin-bd_dom | 7.11e-05 | 2 | 158 | 2 | IPR015009 | |
| Domain | Talin_cent | 7.11e-05 | 2 | 158 | 2 | IPR015224 | |
| Domain | Tyr_kinase_non-rcpt_SYK/ZAP70 | 7.11e-05 | 2 | 158 | 2 | IPR012234 | |
| Domain | Talin_middle | 7.11e-05 | 2 | 158 | 2 | PF09141 | |
| Domain | AP3B1_C | 7.11e-05 | 2 | 158 | 2 | SM01355 | |
| Domain | EF-hand-dom_pair | 1.70e-04 | 287 | 158 | 10 | IPR011992 | |
| Domain | Talin-1 | 2.12e-04 | 3 | 158 | 2 | IPR015710 | |
| Domain | - | 3.89e-04 | 261 | 158 | 9 | 1.10.238.10 | |
| Domain | Ion_trans_dom | 4.19e-04 | 114 | 158 | 6 | IPR005821 | |
| Domain | Ion_trans | 4.19e-04 | 114 | 158 | 6 | PF00520 | |
| Domain | ILWEQ_dom | 4.22e-04 | 4 | 158 | 2 | IPR002558 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | IPR012315 | |
| Domain | ILWEQ | 4.22e-04 | 4 | 158 | 2 | SM00307 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | PS51049 | |
| Domain | FERM_f0 | 4.22e-04 | 4 | 158 | 2 | PF16511 | |
| Domain | TRPM_tetra | 4.22e-04 | 4 | 158 | 2 | PF16519 | |
| Domain | ILWEQ | 4.22e-04 | 4 | 158 | 2 | PD011820 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | SM01249 | |
| Domain | - | 4.22e-04 | 4 | 158 | 2 | 1.20.1410.10 | |
| Domain | I_LWEQ | 4.22e-04 | 4 | 158 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.22e-04 | 4 | 158 | 2 | PS50945 | |
| Domain | KASH | 4.22e-04 | 4 | 158 | 2 | PF10541 | |
| Domain | FERM_f0 | 4.22e-04 | 4 | 158 | 2 | IPR032425 | |
| Domain | TRPM_tetra | 4.22e-04 | 4 | 158 | 2 | IPR032415 | |
| Domain | - | 6.15e-04 | 222 | 158 | 8 | 1.25.10.10 | |
| Domain | AP_beta | 6.99e-04 | 5 | 158 | 2 | IPR026739 | |
| Domain | Spectrin | 9.29e-04 | 23 | 158 | 3 | PF00435 | |
| Domain | Vinculin/catenin | 1.45e-03 | 7 | 158 | 2 | IPR006077 | |
| Domain | DCX | 1.45e-03 | 7 | 158 | 2 | PF03607 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SART3 HK2 HDAC6 EP400 COPG1 ARID4A RBL1 POLR2A SNX17 CKAP5 AGGF1 MRPL45 LMNB2 PFKL MAGT1 SKIL KHSRP TTLL7 LIG3 SUGP2 SUDS3 NCAPD2 SF3A3 PKM ASXL2 QARS1 MRPL24 USP47 | 6.31e-16 | 857 | 163 | 28 | 25609649 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 HK2 HDAC6 EP400 COPG1 POLR2A SNX17 NUMA1 CKAP5 LMNB2 VPS26A ACTN1 PFKL MELK YWHAE NCAPG2 DIS3 SLC2A1 KHSRP PLCD3 LIG3 AP2M1 SUGP2 MTHFD1 NANS FHOD1 TLN1 NCAPD2 SF3A3 PKM SAFB2 QARS1 HDLBP | 5.47e-15 | 1353 | 163 | 33 | 29467282 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM4 SART3 ATP6V1A FKBP15 EP400 CDKN2AIP POLR2A NUMA1 CKAP5 ICE1 PFKL THOC2 AHSA1 DIS3 KHSRP SNAP29 LIG3 AP2M1 SUGP2 MTHFD1 KIAA1217 FHOD1 TLN1 PKM SAFB2 PUS7 HDLBP | 4.17e-14 | 934 | 163 | 27 | 33916271 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 ATP6V1A HK2 COPG1 SYNE1 POLR2A NUMA1 CKAP5 LMNB2 PFKL AP3B1 THOC2 AHSA1 YWHAE DIS3 SLC2A1 KHSRP LIG3 AP2M1 PPP5C MTHFD1 TLN1 NCAPD2 SF3A3 PKM SAFB2 KIF14 TLN2 EEA1 QARS1 HDLBP | 8.30e-13 | 1425 | 163 | 31 | 30948266 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM4 SART3 COL17A1 UACA NUMA1 CKAP5 SRPRA LMNB2 ACTN1 PFKL MAGT1 THOC2 AHSA1 YWHAE SLC2A1 AP2M1 MTHFD1 KIAA1217 FHOD1 SF3A3 PKM SAFB2 KIF14 SPATS2 MICU2 QARS1 MRPL24 EXOSC7 HDLBP | 1.21e-12 | 1257 | 163 | 29 | 36526897 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPM4 SART3 ATP6V1A DNAH3 MYH11 NUMA1 CKAP5 ACTN1 AP3B1 THOC2 YWHAE SLC2A1 KHSRP LIG3 AP2M1 KIAA1217 ATP6V1D TLN1 AP3B2 NCAPD2 SF3A3 TLN2 EEA1 QARS1 | 1.89e-12 | 847 | 163 | 24 | 35235311 |
| Pubmed | TRIM46 TPM4 SART3 ATP6V1A MYH6 MYH11 PACSIN1 VPS45 SYNE1 ARHGAP26 CKAP5 ACTN1 PFKL AP3B1 YWHAE SLC2A1 KHSRP GPD1L AP2M1 SUGP2 MTHFD1 KIAA1217 VCAN ATP6V1D TLN1 AP3B2 PKM TLN2 FGG HDLBP | 5.16e-12 | 1431 | 163 | 30 | 37142655 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM4 SART3 ATP6V1A HK2 HDAC6 COPG1 POLR2A NUMA1 CKAP5 SRPRA ACTN1 PFKL AP3B1 YWHAE DIS3 KHSRP AP2M1 MTHFD1 FHOD1 TLN1 NCAPD2 SF3A3 PKM SPATS2 CARS2 QARS1 EXOSC7 PUS7 HDLBP | 2.11e-11 | 1415 | 163 | 29 | 28515276 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM4 SART3 ATP6V1A HK2 COPG1 HECTD3 POLR2A VPS26A ACTN1 PFKL AP3B1 AHSA1 YWHAE DIS3 KHSRP CUTA PPP5C ARHGEF10 MTHFD1 NANS TLN1 NCAPD2 THG1L SF3A3 PKM QARS1 PUS7 USP47 HDLBP | 4.09e-11 | 1455 | 163 | 29 | 22863883 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1A EP400 SYNE1 POLR2A NUMA1 CKAP5 LMNB2 ACTN1 NUP58 PFKL THOC2 YWHAE KHSRP LIG3 SUGP2 MTHFD1 TLN1 SF3A3 PKM SAFB2 KIF14 EEA1 QARS1 HDLBP | 9.53e-11 | 1024 | 163 | 24 | 24711643 |
| Pubmed | TPM4 SART3 HK2 COPG1 POLR2A NUMA1 MAGT1 AP3B1 CBL DIS3 KHSRP AP2M1 SUDS3 TLN1 SF3A3 SYK SAFB2 EEA1 PUS7 | 2.93e-10 | 653 | 163 | 19 | 33742100 | |
| Pubmed | SART3 EP400 UACA VPS45 SYNE1 CDKN2AIP POLR2A CKAP5 SRPRA ICE1 AIF1L ACTN1 PFKL MAGT1 AP3B1 YWHAE SLC2A1 PLCD3 CDK5RAP3 MTHFD1 MACO1 TLN1 NCAPD2 KIF14 SPATS2 MICU2 EXOSC7 HDLBP | 3.92e-10 | 1497 | 163 | 28 | 31527615 | |
| Pubmed | SART3 ATP6V1A CDKN2AIP CKAP5 SRPRA ACTN1 YWHAE MTHFD1 TLN1 NCAPD2 PKM EEA1 SPATS2 QARS1 USP47 | 7.76e-10 | 399 | 163 | 15 | 37536630 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 HDAC6 UACA COPG1 SYNE1 CDKN2AIP POLR2A NUMA1 CKAP5 AGGF1 AIF1L SNAP29 AP2M1 TLN1 SF3A3 PKM KIF14 TLN2 CEP152 DIXDC1 ASXL2 EEA1 MRPL24 USP47 | 1.06e-09 | 1155 | 163 | 24 | 20360068 |
| Pubmed | FKBP15 CDKN2AIP ENTR1 NUMA1 ARHGAP17 LMNB2 ACTN1 NUP58 YWHAE FHOD1 PKM VPS53 HDLBP | 1.22e-09 | 288 | 163 | 13 | 23383273 | |
| Pubmed | SART3 ATP6V1A COPG1 POLR2A CKAP5 LMNB2 ACTN1 AP3B1 THOC2 AHSA1 YWHAE DIS3 SUGP2 MTHFD1 TLN1 NCAPD2 PKM QARS1 | 1.44e-09 | 638 | 163 | 18 | 33239621 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | SART3 ATP6V1A ARHGAP26 CKAP5 LMNB2 PFKL YWHAE SLC2A1 LIG3 AP2M1 MACO1 KIAA1217 KIF14 FGG SPATS2 CPLANE1 QARS1 MRPL24 EXOSC7 | 1.93e-09 | 732 | 163 | 19 | 34732716 |
| Pubmed | TPM4 SART3 ATP6V1A HK2 UACA COPG1 VPS45 NUMA1 SRPRA MRPL45 PFKL THOC2 YWHAE NCAPG2 DIS3 KHSRP SNAP29 LIG3 AP2M1 MACO1 TLN1 NCAPD2 SF3A3 KIF14 QARS1 VPS53 | 3.74e-09 | 1440 | 163 | 26 | 30833792 | |
| Pubmed | SART3 ATP6V1A FKBP15 HK2 COPG1 VPS45 CKAP5 SRPRA PFKL YWHAE RYR2 KHSRP FABP7 SNAP29 AP2M1 PPP5C KCNB1 SUGP2 MTHFD1 KIAA1217 PKM TLN2 HDLBP | 4.17e-09 | 1139 | 163 | 23 | 36417873 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 SART3 ATP6V1A COPG1 CKAP5 AIF1L ACTN1 PFKL AP3B1 AHSA1 YWHAE KHSRP LIG3 AP2M1 PPP5C MTHFD1 TLN1 NCAPD2 SF3A3 PKM EEA1 QARS1 HDLBP | 4.91e-09 | 1149 | 163 | 23 | 35446349 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP6V1A MYH6 MYH11 LMNB2 ACTN1 PFKL AHSA1 YWHAE LDHC SLC2A1 AP2M1 MTHFD1 ATP6V1D AP3B2 SF3A3 PKM HDLBP | 6.60e-09 | 621 | 163 | 17 | 22794259 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | HK2 EP400 COPG1 POLR2A NUMA1 CKAP5 PFKL MTHFD1 TLN1 NCAPD2 PKM SAFB2 HDLBP | 6.75e-09 | 332 | 163 | 13 | 32786267 |
| Pubmed | EP400 NELFA CDKN2AIP CKAP5 ACTN1 PFKL THOC2 AHSA1 NCAPG2 KHSRP CUTA AP2M1 PPP5C SUGP2 MTHFD1 TLN1 SYK PKM SAFB2 ASXL2 LCOR HDLBP | 1.17e-08 | 1103 | 163 | 22 | 34189442 | |
| Pubmed | SART3 ATP6V1A FKBP15 EP400 NELFA CDKN2AIP POLR2A NUMA1 LMNB2 THOC2 AHSA1 DIS3 KHSRP LIG3 AP2M1 SUGP2 SUDS3 NANS NCAPD2 SAFB2 PUS7 | 1.36e-08 | 1014 | 163 | 21 | 32416067 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SART3 POLR2A NUMA1 SRPRA AP3B1 DIS3 FABP7 AP2M1 SUGP2 NANS VCAN AP3B2 TLN2 CARS2 HDLBP | 1.53e-08 | 498 | 163 | 15 | 36634849 |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 1.66e-08 | 182 | 163 | 10 | 31067453 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SART3 EP400 NELFA CDKN2AIP SRPRA ACTN1 AHSA1 DIS3 LIG3 FHOD1 TLN1 MITF PKM HDLBP | 2.67e-08 | 444 | 163 | 14 | 34795231 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPM4 HDAC6 COPG1 CKAP5 VPS26A ACTN1 PFKL MAGT1 YWHAE DIS3 SLC2A1 KHSRP SNAP29 AP2M1 CDK5RAP3 PPP5C TLN1 NCAPD2 SF3A3 PKM QARS1 EXOSC7 PUS7 HDLBP | 2.71e-08 | 1367 | 163 | 24 | 32687490 |
| Pubmed | TPM4 SART3 ATP6V1A MYH11 EP400 UACA COPG1 NUMA1 SRPRA MAGT1 AP3B1 THOC2 YWHAE KHSRP CUTA AP2M1 SUGP2 TLN1 PKM TRPM1 EEA1 SPATS2 QARS1 HDLBP | 2.87e-08 | 1371 | 163 | 24 | 36244648 | |
| Pubmed | SART3 EP400 PACSIN1 ARHGAP26 SNX17 ICE1 NUP58 MELK DIS3 ARHGEF10L NCAPD2 DIXDC1 EXOSC7 PADI2 LCOR | 3.38e-08 | 529 | 163 | 15 | 14621295 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 FKBP15 COPG1 DTNB ARHGAP26 CKAP5 SRPRA VPS26A AP3B1 YWHAE NCAPG2 DIS3 KHSRP AP2M1 PPP5C MACO1 SF3A3 PADI2 PUS7 USP47 | 3.56e-08 | 974 | 163 | 20 | 28675297 |
| Pubmed | TPM4 ATP6V1A DNAH3 SYNE1 LMNB2 VPS26A PFKL YWHAE SLC2A1 KHSRP CUTA AP2M1 MTHFD1 TLN1 PKM TRPM1 QARS1 HDLBP | 4.92e-08 | 803 | 163 | 18 | 36517590 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP6V1A MYH11 COPG1 SYNE1 POLR2A CNTRL NUMA1 ACTN1 AP3B1 YWHAE AP2M1 MTHFD1 NANS TLN1 PKM EEA1 QARS1 HDLBP | 5.30e-08 | 807 | 163 | 18 | 30575818 |
| Pubmed | EP400 POLR2A NUMA1 ACTN1 AP3B1 THOC2 CBL KHSRP SNAP29 SUGP2 TLN1 NCAPD2 PKM KIF14 HDLBP | 5.49e-08 | 549 | 163 | 15 | 38280479 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | DNAH3 EP400 TIGD1 SRPRA MRPL45 LMNB2 MELK KHSRP CDK5RAP3 SF3A3 SPATS2 EXOSC7 VPS53 | 8.03e-08 | 410 | 163 | 13 | 26949251 |
| Pubmed | TPM4 MYH11 PACSIN1 SYNE1 CNTRL ARHGAP17 ACTN1 NUP58 CBL YWHAE MAP3K4 FHOD1 CPLANE1 HDLBP | 8.15e-08 | 486 | 163 | 14 | 20936779 | |
| Pubmed | SART3 COPG1 POLR2A NUMA1 CKAP5 LMNB2 ACTN1 THOC2 DIS3 KHSRP SUGP2 TLN1 NCAPD2 KIF14 USP47 HDLBP | 8.61e-08 | 653 | 163 | 16 | 22586326 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | TPM4 MYH11 HDAC6 UACA COPG1 SRPRA ACTN1 AHSA1 YWHAE PLCD3 LIG3 AP2M1 MTHFD1 PKM QARS1 | 1.12e-07 | 580 | 163 | 15 | 35676659 |
| Pubmed | HDAC6 VPS45 SYNE1 CKAP5 VPS26A ACTN1 NUP58 SKIL YWHAE BICD1 LIMK1 AP2M1 PPP5C ARHGEF10 PKM TLN2 CARS2 QARS1 PADI2 LCOR RECK USP47 | 1.68e-07 | 1285 | 163 | 22 | 35914814 | |
| Pubmed | 1.71e-07 | 177 | 163 | 9 | 26206133 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | TPM4 FKBP15 CDKN2AIP POLR2A CKAP5 SRPRA YWHAE DIS3 AP2M1 CDK5RAP3 TLN1 SYK PKM SAFB2 EXOSC7 HDLBP | 2.24e-07 | 701 | 163 | 16 | 30196744 |
| Pubmed | COPG1 CKAP5 VPS26A PFKL THOC2 YWHAE SLC2A1 KHSRP SNAP29 AP2M1 MTHFD1 TLN1 SF3A3 SYK PKM QARS1 | 2.51e-07 | 707 | 163 | 16 | 19738201 | |
| Pubmed | HDAC6 NUMA1 CKAP5 SRPRA MAGT1 AP3B1 YWHAE SNAP29 CDK5RAP3 MTHFD1 TLN1 NCAPD2 PKM LRP6 QARS1 HDLBP | 2.56e-07 | 708 | 163 | 16 | 39231216 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | ATP6V1A EP400 COPG1 CDKN2AIP NUMA1 SRPRA VPS26A PFKL MAGT1 AP3B1 THOC2 AHSA1 DIS3 SLC2A1 KHSRP AP2M1 MTHFD1 SF3A3 PKM SAFB2 QARS1 MRPL24 | 2.59e-07 | 1318 | 163 | 22 | 30463901 |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | DTNB SLC2A1 MAP3K4 SUGP2 MTHFD1 KIAA1217 SYK PKM TLN2 CEP152 PLCB4 SPATS2 BRD1 LCOR | 2.67e-07 | 536 | 163 | 14 | 15840001 |
| Pubmed | DTNB SLC2A1 MAP3K4 SUGP2 MTHFD1 KIAA1217 SYK PKM TLN2 CEP152 PLCB4 SPATS2 BRD1 LCOR | 2.80e-07 | 538 | 163 | 14 | 10512203 | |
| Pubmed | SART3 HDAC6 COPG1 CDKN2AIP AP3B1 AHSA1 YWHAE KHSRP SUGP2 MTHFD1 SF3A3 PKM QARS1 | 3.73e-07 | 469 | 163 | 13 | 37314180 | |
| Pubmed | Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases. | 4.03e-07 | 4 | 163 | 3 | 8798454 | |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 4.22e-07 | 197 | 163 | 9 | 29872149 | |
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | POLR2A NUMA1 SRPRA PFKL CBL ZAP70 TLN1 SF3A3 PKM QARS1 HDLBP | 4.62e-07 | 327 | 163 | 11 | 15592455 |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 4.78e-07 | 62 | 163 | 6 | 26508657 | |
| Pubmed | SART3 UACA HECTD3 SYNE1 ENTR1 SRPRA MRPL45 LMNB2 MAGT1 AP3B1 NCAPG2 SLC2A1 CDK5RAP3 SYNE3 PPP5C ARHGEF10 MACO1 TLN1 CARS2 MRPL24 ATPAF1 PUS7 HDLBP | 5.10e-07 | 1487 | 163 | 23 | 33957083 | |
| Pubmed | 5.15e-07 | 263 | 163 | 10 | 12665801 | ||
| Pubmed | SART3 UACA SYNE1 POLR2A NUMA1 CKAP5 NUP58 MEAK7 SPATS2 BRD1 EXOSC7 | 5.37e-07 | 332 | 163 | 11 | 25693804 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TPM4 FKBP15 HDAC6 EP400 SYNE1 POLR2A MRPL45 LMNB2 THOC2 SLC2A1 KHSRP LIG3 AP2M1 ZBED4 SUGP2 VCAN SF3A3 PKM SAFB2 | 8.61e-07 | 1082 | 163 | 19 | 38697112 |
| Pubmed | TPM4 ATP6V1A MYH11 COPG1 NUMA1 LMNB2 ACTN1 AHSA1 YWHAE CUTA DHRS4 MTHFD1 TLN1 SAFB2 QARS1 HDLBP | 1.01e-06 | 786 | 163 | 16 | 29128334 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SART3 FKBP15 RBL1 VPS45 ARHGAP26 ACTN1 MAGT1 AP3B1 MELK YWHAE NCAPG2 DIS3 SNAP29 AP2M1 NANS SF3A3 EEA1 QARS1 EXOSC7 VPS53 CCDC40 | 1.09e-06 | 1321 | 163 | 21 | 27173435 |
| Pubmed | 1.17e-06 | 72 | 163 | 6 | 36376293 | ||
| Pubmed | NUMA1 ARHGAP17 LMNB2 LIG3 DHRS4 KIAA1217 ATP6V1D TLN1 PKM EEA1 ATPAF1 | 1.18e-06 | 360 | 163 | 11 | 33111431 | |
| Pubmed | A proteomic snapshot of the human heat shock protein 90 interactome. | 1.23e-06 | 40 | 163 | 5 | 16263121 | |
| Pubmed | SLAP, a dimeric adapter protein, plays a functional role in T cell receptor signaling. | 2.00e-06 | 6 | 163 | 3 | 10449770 | |
| Pubmed | SART3 COPG1 MRPL45 AHSA1 DIS3 KHSRP AP2M1 PPP5C SUGP2 MTHFD1 FHOD1 EXOSC7 HDLBP | 2.06e-06 | 547 | 163 | 13 | 37267103 | |
| Pubmed | FKBP15 EP400 POLR2A ENTR1 ARHGAP17 SRPRA ICE1 AIF1L LMNB2 MELK AP2M1 ARHGEF10 MACO1 SF3A3 KIF14 | 2.10e-06 | 733 | 163 | 15 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DNAH3 COPG1 POLR2A CKAP5 SRPRA ICE1 LMNB2 PFKL FABP7 LIG3 ZBED4 TRPM3 MTHFD1 TLN1 PKM | 2.21e-06 | 736 | 163 | 15 | 29676528 |
| Pubmed | 2.40e-06 | 312 | 163 | 10 | 37120454 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPM4 MYH6 MYH11 COPG1 LMNB2 ACTN1 PFKL AHSA1 YWHAE KHSRP MTHFD1 NCAPD2 PKM QARS1 | 2.46e-06 | 647 | 163 | 14 | 26618866 |
| Pubmed | 2.62e-06 | 21 | 163 | 4 | 31541095 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART3 EP400 ARID4A CDKN2AIP POLR2A NUMA1 ICE1 THOC2 YWHAE KHSRP LIG3 DHRS4 SUGP2 SF3A3 SAFB2 LCOR HDLBP | 2.77e-06 | 954 | 163 | 17 | 36373674 |
| Pubmed | 2.84e-06 | 248 | 163 | 9 | 32963011 | ||
| Pubmed | 2.84e-06 | 130 | 163 | 7 | 12421765 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ATP6V1A NUMA1 LMNB2 YWHAE DIS3 KHSRP SUGP2 MTHFD1 FHOD1 TLN1 PKM HDLBP | 2.89e-06 | 477 | 163 | 12 | 31300519 |
| Pubmed | ATP6V1A EP400 COPG1 RBL1 SYNE1 POLR2A CNTRL LMNB2 VPS26A KHSRP LIG3 SF3A3 SAFB2 KIF14 HDLBP | 2.96e-06 | 754 | 163 | 15 | 35906200 | |
| Pubmed | TPM4 SART3 NUMA1 ACTN1 YWHAE KHSRP MTHFD1 TLN1 PKM QARS1 HDLBP | 3.04e-06 | 397 | 163 | 11 | 21319273 | |
| Pubmed | COPG1 ARID4A VPS45 NUMA1 CKAP5 SRPRA LMNB2 AP3B1 SNAP29 CDK5RAP3 MACO1 TLN1 HDLBP | 3.11e-06 | 568 | 163 | 13 | 37774976 | |
| Pubmed | 3.64e-06 | 327 | 163 | 10 | 31409639 | ||
| Pubmed | TPM4 MYH6 MYH11 DHRS4L2 VPS26A RYR2 FSIP2 DHRS4 AP2M1 CPLANE1 | 4.05e-06 | 331 | 163 | 10 | 29199018 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | HDAC6 EP400 UACA ARID4A NELFA POLR2A NUMA1 CKAP5 THOC2 SUGP2 FHOD1 SAFB2 TLN2 USP47 HDLBP | 4.06e-06 | 774 | 163 | 15 | 15302935 |
| Pubmed | SART3 COPG1 NUMA1 CKAP5 PFKL YWHAE KHSRP MTHFD1 TLN1 SF3A3 PKM QARS1 | 4.13e-06 | 494 | 163 | 12 | 26831064 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | POLR2A NUMA1 SRPRA LMNB2 ACTN1 THOC2 AHSA1 DIS3 KHSRP AP2M1 SUGP2 MTHFD1 SF3A3 PKM SAFB2 QARS1 EXOSC7 | 4.47e-06 | 989 | 163 | 17 | 36424410 |
| Pubmed | SART3 EP400 NELFA NUMA1 YWHAE KHSRP SNAP29 MTHFD1 TLN1 SF3A3 QARS1 PUS7 | 5.27e-06 | 506 | 163 | 12 | 30890647 | |
| Pubmed | 5.42e-06 | 202 | 163 | 8 | 24639526 | ||
| Pubmed | 5.45e-06 | 25 | 163 | 4 | 12522145 | ||
| Pubmed | Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. | 5.56e-06 | 8 | 163 | 3 | 9846481 | |
| Pubmed | The involvement of the proto-oncogene p120 c-Cbl and ZAP-70 in CD2-mediated T cell activation. | 5.56e-06 | 8 | 163 | 3 | 11133830 | |
| Pubmed | UACA COPG1 POLR2A NUMA1 PFKL MAGT1 YWHAE DIS3 SUGP2 ARHGEF10 MTHFD1 EEA1 HDLBP | 5.71e-06 | 601 | 163 | 13 | 33658012 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.83e-06 | 271 | 163 | 9 | 32433965 | |
| Pubmed | 5.95e-06 | 95 | 163 | 6 | 33863777 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | COPG1 NUMA1 LMNB2 PFKL DIS3 MTHFD1 NANS TLN1 SF3A3 FGG EEA1 QARS1 HDLBP | 6.36e-06 | 607 | 163 | 13 | 39147351 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V1A UACA AIF1L ACTN1 PFKL AHSA1 YWHAE CUTA AP2M1 MTHFD1 SUSD2 ATP6V1D TLN1 PKM FGG EEA1 PADI2 | 6.36e-06 | 1016 | 163 | 17 | 19056867 |
| Pubmed | 6.41e-06 | 147 | 163 | 7 | 29576527 | ||
| Pubmed | ATP6V1A UACA POLR2A NUMA1 PFKL AP3B1 THOC2 AHSA1 YWHAE DIS3 LIG3 AP2M1 PPP5C MTHFD1 TLN1 PKM SPATS2 QARS1 HDLBP | 6.73e-06 | 1247 | 163 | 19 | 27684187 | |
| Pubmed | POLR2A NUMA1 CKAP5 LMNB2 AHSA1 KHSRP LIG3 MTHFD1 PKM SAFB2 QARS1 | 8.21e-06 | 441 | 163 | 11 | 31239290 | |
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 15536084 | ||
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | TPM4 UACA COPG1 NUMA1 ACTN1 YWHAE ZAP70 SLC2A1 KHSRP LIG3 KIAA1217 SYK PKM | 8.83e-06 | 626 | 163 | 13 | 33644029 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | UACA COPG1 CKAP5 SRPRA PFKL AP3B1 KHSRP SUGP2 TLN1 SPATS2 QARS1 EXOSC7 LCOR HDLBP | 8.83e-06 | 724 | 163 | 14 | 36232890 |
| Pubmed | HK2 DHRS4L2 POLR2A CKAP5 MAGT1 THOC2 AHSA1 YWHAE DIS3 MTHFD1 CARS2 HDLBP | 9.05e-06 | 534 | 163 | 12 | 35032548 | |
| Pubmed | FKBP15 HDAC6 NELFA ENTR1 SRPRA THOC2 CBL YWHAE KIF14 CEP152 QARS1 | 9.12e-06 | 446 | 163 | 11 | 24255178 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ATP6V1A MYH11 HK2 COPG1 HECTD3 SRPRA LMNB2 MAGT1 AP3B1 NCAPG2 TLN1 NCAPD2 LRP6 QARS1 VPS53 HDLBP | 1.00e-05 | 942 | 163 | 16 | 31073040 |
| Pubmed | COPG1 ACTN1 AP3B1 NCAPG2 DIS3 KHSRP MTHFD1 SF3A3 PKM QARS1 VPS53 | 1.01e-05 | 451 | 163 | 11 | 36168627 | |
| Pubmed | FKBP15 HK2 CNTRL CKAP5 PFKL MAGT1 AP3B1 MELK YWHAE NCAPG2 DIS3 KHSRP CDK5RAP3 SYNE3 MTHFD1 FHOD1 NCAPD2 KIF14 | 1.03e-05 | 1168 | 163 | 18 | 19946888 | |
| Interaction | NAA40 interactions | TPM4 SART3 ATP6V1A FKBP15 EP400 CDKN2AIP POLR2A NUMA1 CKAP5 ICE1 PFKL THOC2 AHSA1 DIS3 KHSRP SNAP29 LIG3 AP2M1 SUGP2 MTHFD1 KIAA1217 FHOD1 TLN1 PKM SAFB2 PUS7 HDLBP | 1.40e-08 | 978 | 160 | 27 | int:NAA40 |
| Interaction | EED interactions | TPM4 MYH11 HK2 EP400 COPG1 RBL1 VPS45 POLR2A NUMA1 CKAP5 LMNB2 ACTN1 PFKL MAGT1 AP3B1 THOC2 CBL AHSA1 DIS3 SLC2A1 KHSRP LIG3 AP2M1 MTHFD1 SUDS3 TLN1 NCAPD2 SF3A3 PKM SAFB2 LCOR VPS53 HDLBP | 2.86e-08 | 1445 | 160 | 33 | int:EED |
| Interaction | FOXB1 interactions | 1.26e-07 | 135 | 160 | 10 | int:FOXB1 | |
| Interaction | KCTD13 interactions | TRIM46 TPM4 SART3 ATP6V1A MYH6 MYH11 PACSIN1 VPS45 SYNE1 ARHGAP26 CKAP5 ACTN1 PFKL AP3B1 YWHAE SLC2A1 KHSRP FABP7 GPD1L AP2M1 SUGP2 MTHFD1 KIAA1217 VCAN ATP6V1D TLN1 AP3B2 PKM TLN2 FGG HDLBP | 1.48e-07 | 1394 | 160 | 31 | int:KCTD13 |
| Interaction | HDAC6 interactions | TPM4 FKBP15 GLOD5 MYH11 HDAC6 EP400 UACA COPG1 SRPRA ACTN1 PFKL AHSA1 YWHAE PLCD3 LIG3 AP2M1 MTHFD1 SYK PKM KIF14 BRD1 QARS1 LCOR USP47 | 3.33e-07 | 929 | 160 | 24 | int:HDAC6 |
| Interaction | STIP1 interactions | SART3 ATP6V1A HDAC6 COPG1 POLR2A ENTR1 CKAP5 LMNB2 ACTN1 AP3B1 THOC2 AHSA1 YWHAE DIS3 ARHGEF10L LIG3 PPP5C SUGP2 ARHGEF10 MTHFD1 KCNQ4 TLN1 NCAPD2 PKM QARS1 | 3.79e-07 | 1006 | 160 | 25 | int:STIP1 |
| Interaction | RICTOR interactions | TPM4 SART3 HK2 COPG1 CKAP5 LMNB2 ACTN1 AHSA1 YWHAE DIS3 KHSRP DHRS4 SUGP2 MTHFD1 NANS TLN1 PKM KIF14 BRD1 PUS7 HDLBP | 6.53e-07 | 759 | 160 | 21 | int:RICTOR |
| Interaction | MAPT interactions | ATP6V1A HDAC6 PACSIN1 CKAP5 SRPRA ACTN1 MND1 PFKL AHSA1 MELK YWHAE SLC2A1 SNAP29 FSIP2 AP2M1 PPP5C MTHFD1 NANS TLN1 AP3B2 SCN7A SF3A3 SYK PKM CEP152 CARS2 | 7.74e-07 | 1119 | 160 | 26 | int:MAPT |
| Interaction | MOB3C interactions | SART3 ATP6V1A CDKN2AIP CKAP5 SRPRA YWHAE MTHFD1 TLN1 NCAPD2 PKM EEA1 SPATS2 QARS1 USP47 | 1.30e-06 | 364 | 160 | 14 | int:MOB3C |
| Interaction | ATG16L1 interactions | TPM4 FKBP15 ARHGEF28 VPS45 CDKN2AIP POLR2A ENTR1 CNTRL CKAP5 SRPRA YWHAE DIS3 RYR2 AP2M1 CDK5RAP3 KIAA1217 TLN1 MITF SYK PKM SAFB2 KIF14 CEP152 DIXDC1 EXOSC7 HDLBP | 1.54e-06 | 1161 | 160 | 26 | int:ATG16L1 |
| Interaction | KCNA3 interactions | HDAC6 NUMA1 CKAP5 SRPRA MAGT1 AP3B1 THOC2 YWHAE SLC2A1 SNAP29 CDK5RAP3 MTHFD1 TLN1 AP3B2 NCAPD2 PKM LRP6 TLN2 TRPM1 RP1 QARS1 HDLBP | 1.57e-06 | 871 | 160 | 22 | int:KCNA3 |
| Interaction | EFTUD2 interactions | TPM4 SART3 HDAC6 COPG1 POLR2A NUMA1 CKAP5 SRPRA PFKL AP3B1 AHSA1 YWHAE DIS3 KHSRP AP2M1 MTHFD1 FHOD1 TLN1 NCAPD2 SF3A3 PKM KIF14 ASXL2 SPATS2 CARS2 QARS1 EXOSC7 PUS7 HDLBP | 3.35e-06 | 1449 | 160 | 29 | int:EFTUD2 |
| Interaction | PML interactions | SART3 HDAC6 EP400 NELFA NUMA1 SRPRA ACTN1 PFKL SKIL THOC2 AHSA1 DIS3 LIG3 MTHFD1 FHOD1 TLN1 MITF PKM KIF14 BRD1 AIM2 HDLBP | 4.78e-06 | 933 | 160 | 22 | int:PML |
| Interaction | PDIA3 interactions | ATP6V1A HDAC6 CNTRL MND1 PFKL SLC2A1 FSIP2 CDK5RAP3 SYNE3 NANS PKM KIF14 CARS2 FILIP1L HDLBP | 6.23e-06 | 476 | 160 | 15 | int:PDIA3 |
| Interaction | BIRC3 interactions | SART3 ATP6V1A COPG1 SYNE1 POLR2A NUMA1 CKAP5 LMNB2 PFKL AP3B1 THOC2 AHSA1 YWHAE DIS3 KHSRP LIG3 AP2M1 PPP5C MTHFD1 TLN1 NCAPD2 SF3A3 PKM TLN2 EEA1 QARS1 HDLBP | 6.28e-06 | 1334 | 160 | 27 | int:BIRC3 |
| Interaction | RHOF interactions | TPM4 HDAC6 UACA COPG1 VPS45 SRPRA HEATR5A LMNB2 ACTN1 MAGT1 MELK DIS3 SLC2A1 SNAP29 LIG3 NCAPD2 KIF14 PLCB4 | 6.98e-06 | 673 | 160 | 18 | int:RHOF |
| Interaction | CKB interactions | TPM4 HDAC6 CNTRL ARHGAP17 ACTN1 PFKL YWHAE BICD1 FHAD1 NANS HDLBP | 1.09e-05 | 270 | 160 | 11 | int:CKB |
| Interaction | VPS35 interactions | ATP6V1A FKBP15 HDAC6 ENTR1 VPS26A CBL PKM KIF14 ASXL2 EEA1 HDLBP | 1.09e-05 | 270 | 160 | 11 | int:VPS35 |
| Interaction | ZYX interactions | TPM4 FKBP15 ENTR1 ACTN1 CBL AHSA1 YWHAE ARHGEF10 KIAA1217 TLN2 CEP152 HDLBP | 1.31e-05 | 329 | 160 | 12 | int:ZYX |
| Interaction | MAPRE1 interactions | TPM4 HDAC6 NUMA1 CKAP5 ARHGAP17 LMNB2 ACTN1 NUP58 CBL BICD1 CDK5RAP3 KIAA1217 KIF14 BRD1 QARS1 | 1.55e-05 | 514 | 160 | 15 | int:MAPRE1 |
| Interaction | CDC42 interactions | ATP6V1A HDAC6 FGD2 COPG1 VPS45 SYNE1 ARHGAP26 SNX17 ARHGAP17 SRPRA LMNB2 MAGT1 CBL MELK YWHAE NCAPG2 SLC2A1 MAP3K4 SNAP29 ARHGEF10 MACO1 FHOD1 NCAPD2 KIF14 PLCB4 HDLBP | 1.60e-05 | 1323 | 160 | 26 | int:CDC42 |
| Interaction | MKI67 interactions | DNAH3 EP400 TIGD1 NUMA1 SRPRA MRPL45 LMNB2 MELK KHSRP LIMK1 CDK5RAP3 SF3A3 KIF14 SPATS2 EXOSC7 VPS53 HDLBP | 1.63e-05 | 648 | 160 | 17 | int:MKI67 |
| Interaction | CEBPA interactions | EP400 RBL1 NELFA CDKN2AIP POLR2A CKAP5 ACTN1 PFKL THOC2 AHSA1 NCAPG2 KHSRP LIG3 CUTA AP2M1 PPP5C SUGP2 MTHFD1 TLN1 SYK PKM SAFB2 ASXL2 LCOR HDLBP | 1.66e-05 | 1245 | 160 | 25 | int:CEBPA |
| Interaction | SNRNP27 interactions | 1.67e-05 | 184 | 160 | 9 | int:SNRNP27 | |
| Interaction | ARHGAP44 interactions | 1.76e-05 | 41 | 160 | 5 | int:ARHGAP44 | |
| Interaction | CLTC interactions | FKBP15 HDAC6 CNTRL CKAP5 ACTN1 AP3B1 YWHAE AP2M1 MTHFD1 ATP6V1D TLN1 AP3B2 KIF14 ASXL2 BRD1 QARS1 HDLBP | 1.87e-05 | 655 | 160 | 17 | int:CLTC |
| Interaction | HTT interactions | ATP6V1A MYH6 MYH11 PACSIN1 POLR2A LMNB2 ACTN1 NUP58 PFKL AHSA1 YWHAE LDHC SLC2A1 LIG3 AP2M1 MTHFD1 ATP6V1D AP3B2 SF3A3 PKM HDLBP | 2.08e-05 | 949 | 160 | 21 | int:HTT |
| Interaction | ACE2 interactions | TPM4 SART3 HK2 SNX17 NUMA1 CKAP5 ACTN1 PFKL YWHAE DIS3 SLC2A1 KHSRP SNAP29 LIG3 AP2M1 MTHFD1 TLN1 NCAPD2 SF3A3 PKM SAFB2 EEA1 QARS1 | 2.18e-05 | 1106 | 160 | 23 | int:ACE2 |
| Interaction | CEP128 interactions | DTNB VPS45 POLR2A ENTR1 CNTRL CKAP5 CBL BICD1 SYNE3 KIF14 CEP152 | 2.63e-05 | 297 | 160 | 11 | int:CEP128 |
| Interaction | IFITM1 interactions | TPM4 ATP6V1A FKBP15 VPS45 AIF1L LMNB2 ACTN1 PFKL LIG3 AP2M1 ATP6V1D EEA1 | 2.77e-05 | 355 | 160 | 12 | int:IFITM1 |
| Interaction | SORBS2 interactions | 2.97e-05 | 111 | 160 | 7 | int:SORBS2 | |
| Interaction | GAPDH interactions | ARHGEF28 HDAC6 DTNB PFKL CBL YWHAE SLC2A1 GPD1L AP2M1 PPP5C TLN1 PKM KIF14 TLN2 ASXL2 QARS1 HDLBP | 3.36e-05 | 686 | 160 | 17 | int:GAPDH |
| Interaction | ARHGEF2 interactions | TPM4 FKBP15 HDAC6 ARHGAP26 CNTRL AP3B1 YWHAE BICD1 KIF14 HDLBP | 3.94e-05 | 256 | 160 | 10 | int:ARHGEF2 |
| Interaction | CD274 interactions | COPG1 CKAP5 SRPRA MAGT1 AP3B1 YWHAE DIS3 KHSRP CDK5RAP3 MTHFD1 PKM KIF14 | 4.03e-05 | 369 | 160 | 12 | int:CD274 |
| Interaction | EP300 interactions | TPM4 SART3 HK2 HDAC6 COPG1 RBL1 VPS45 POLR2A NUMA1 MAGT1 AP3B1 CBL DIS3 KHSRP AP2M1 SUDS3 TLN1 MITF SF3A3 SYK PKM SAFB2 KIF14 EEA1 QARS1 PUS7 | 4.26e-05 | 1401 | 160 | 26 | int:EP300 |
| Interaction | DKK2 interactions | 4.26e-05 | 49 | 160 | 5 | int:DKK2 | |
| Interaction | SIPA1L3 interactions | 4.39e-05 | 118 | 160 | 7 | int:SIPA1L3 | |
| Interaction | XRCC6 interactions | SART3 HDAC6 EP400 CDKN2AIP NUMA1 ICE1 SKIL THOC2 CBL AHSA1 KHSRP LIG3 SUGP2 MTHFD1 NCAPD2 SAFB2 KIF14 ASXL2 AIM2 HDLBP | 4.81e-05 | 928 | 160 | 20 | int:XRCC6 |
| Interaction | HDLBP interactions | SART3 EP400 UACA COPG1 NUMA1 VPS26A MAGT1 AP3B1 THOC2 YWHAE KHSRP SUGP2 MTHFD1 PKM TRPM1 SPATS2 QARS1 USP47 HDLBP | 5.02e-05 | 855 | 160 | 19 | int:HDLBP |
| Interaction | AGR2 interactions | ATP6V1A MYH11 COPG1 SYNE1 POLR2A CNTRL NUMA1 ACTN1 NUP58 AP3B1 YWHAE ZAP70 AP2M1 MTHFD1 NANS TLN1 PKM EEA1 QARS1 HDLBP | 5.26e-05 | 934 | 160 | 20 | int:AGR2 |
| Interaction | IFI16 interactions | SART3 UACA SYNE1 POLR2A NUMA1 CKAP5 NUP58 MEAK7 LIG3 SF3A3 PKM SAFB2 KIF14 SPATS2 BRD1 QARS1 EXOSC7 | 5.53e-05 | 714 | 160 | 17 | int:IFI16 |
| Interaction | SNCA interactions | SART3 HDAC6 POLR2A NUMA1 SRPRA AP3B1 YWHAE DIS3 FABP7 AP2M1 SUGP2 VCAN AP3B2 SYK TLN2 USP47 HDLBP | 5.72e-05 | 716 | 160 | 17 | int:SNCA |
| Interaction | SORBS1 interactions | 5.73e-05 | 123 | 160 | 7 | int:SORBS1 | |
| Interaction | GLOD5 interactions | 6.26e-05 | 2 | 160 | 2 | int:GLOD5 | |
| Interaction | VCP interactions | ATP6V1A FKBP15 HDAC6 COPG1 DTNB CDKN2AIP POLR2A ENTR1 NUMA1 ARHGAP17 LMNB2 ACTN1 NUP58 MAGT1 YWHAE KHSRP AP2M1 PPP5C FHOD1 ATP6V1D PKM KIF14 ASXL2 EEA1 VPS53 HDLBP | 6.34e-05 | 1435 | 160 | 26 | int:VCP |
| Interaction | NUP62 interactions | FKBP15 DTNB ENTR1 NUMA1 HEATR5A NUP58 SYNE3 SAFB2 SPATS2 VPS53 | 6.75e-05 | 273 | 160 | 10 | int:NUP62 |
| Interaction | CIT interactions | TPM4 MYH11 EP400 SYNE1 POLR2A NUMA1 CKAP5 SRPRA HEATR5A LMNB2 ACTN1 PFKL THOC2 SLC2A1 MAP3K4 KHSRP BICD1 LIG3 AP2M1 SUGP2 SF3A3 SAFB2 KIF14 QARS1 CCDC40 HDLBP | 7.53e-05 | 1450 | 160 | 26 | int:CIT |
| Interaction | PXN interactions | HDAC6 ENTR1 ACTN1 CBL BICD1 LIMK1 KIAA1217 TLN1 SYK KIF14 CEP152 | 7.60e-05 | 334 | 160 | 11 | int:PXN |
| Interaction | SLA interactions | 7.78e-05 | 29 | 160 | 4 | int:SLA | |
| Interaction | ACTN4 interactions | TPM4 ATP6V1A MYH6 COL17A1 HDAC6 AIF1L ACTN1 YWHAE NCAPG2 SF3A3 KIF14 PUS7 | 8.72e-05 | 400 | 160 | 12 | int:ACTN4 |
| Interaction | OBSL1 interactions | EP400 SYNE1 POLR2A NUMA1 LMNB2 ACTN1 NUP58 THOC2 YWHAE KHSRP CUTA SUGP2 TLN1 SF3A3 PKM SAFB2 KIF14 EXOSC7 HDLBP | 1.02e-04 | 902 | 160 | 19 | int:OBSL1 |
| Interaction | RGCC interactions | 1.03e-04 | 12 | 160 | 3 | int:RGCC | |
| Interaction | HSF1 interactions | ATP6V1A EP400 COPG1 HECTD3 POLR2A VPS26A YWHAE LIG3 DHRS4 MTHFD1 SF3A3 PKM SAFB2 CPLANE1 HDLBP | 1.06e-04 | 609 | 160 | 15 | int:HSF1 |
| Interaction | HAPSTR1 interactions | ATP6V1A COPG1 ABHD18 ARID4A HECTD3 CKAP5 PFKL AHSA1 DIS3 KHSRP MTHFD1 NANS TLN1 NCAPD2 SF3A3 PKM KIF14 CPLANE1 | 1.07e-04 | 829 | 160 | 18 | int:HAPSTR1 |
| Interaction | DDR2 interactions | 1.08e-04 | 136 | 160 | 7 | int:DDR2 | |
| Interaction | BAP1 interactions | TPM4 SART3 ATP6V1A COPG1 CKAP5 AIF1L ACTN1 PFKL AP3B1 AHSA1 YWHAE KHSRP LIG3 AP2M1 PPP5C MTHFD1 TLN1 NCAPD2 SF3A3 PKM ASXL2 EEA1 QARS1 HDLBP | 1.11e-04 | 1314 | 160 | 24 | int:BAP1 |
| Interaction | CDK9 interactions | TPM4 SART3 RBL1 POLR2A NUMA1 CKAP5 ARHGAP17 ACTN1 PFKL AHSA1 ARHGEF10L KHSRP PPP5C SF3A3 PKM KIF14 | 1.15e-04 | 685 | 160 | 16 | int:CDK9 |
| Interaction | MAPK14 interactions | FKBP15 CBL YWHAE ZAP70 BICD1 LIMK1 CDK5RAP3 MITF EEA1 LCOR USP47 | 1.24e-04 | 353 | 160 | 11 | int:MAPK14 |
| Interaction | ERC1 interactions | 1.27e-04 | 187 | 160 | 8 | int:ERC1 | |
| Interaction | ACTC1 interactions | SART3 HDAC6 EP400 NELFA SYNE1 NUMA1 YWHAE KHSRP SNAP29 MTHFD1 TLN1 PHACTR3 SF3A3 KIF14 QARS1 PUS7 | 1.34e-04 | 694 | 160 | 16 | int:ACTC1 |
| Interaction | CUL7 interactions | TPM4 ATP6V1A CETN1 POLR2A NUMA1 LMNB2 ACTN1 PFKL THOC2 YWHAE KHSRP MTHFD1 TLN1 SF3A3 PKM SAFB2 BRD1 QARS1 | 1.36e-04 | 845 | 160 | 18 | int:CUL7 |
| Interaction | FKBP15 interactions | 1.39e-04 | 99 | 160 | 6 | int:FKBP15 | |
| Interaction | BRCA1 interactions | TRIM46 SART3 HK2 COPG1 HECTD3 CETN1 RBL1 CDKN2AIP POLR2A NUMA1 CKAP5 PFKL YWHAE NCAPG2 LDHC KHSRP MTHFD1 TLN1 SF3A3 PKM BRD1 QARS1 HDLBP | 1.39e-04 | 1249 | 160 | 23 | int:BRCA1 |
| Interaction | SOX2 interactions | SART3 ATP6V1A EP400 ARHGAP26 NUMA1 CKAP5 LMNB2 PFKL YWHAE SLC2A1 KHSRP LIG3 AP2M1 SUGP2 MACO1 KIAA1217 NCAPD2 MITF KIF14 FGG SPATS2 CPLANE1 QARS1 MRPL24 EXOSC7 | 1.44e-04 | 1422 | 160 | 25 | int:SOX2 |
| Interaction | WWTR1 interactions | EP400 POLR2A NUMA1 AP3B1 CBL YWHAE KHSRP SNAP29 SUGP2 TLN1 NCAPD2 HDLBP | 1.44e-04 | 422 | 160 | 12 | int:WWTR1 |
| Interaction | PTEN interactions | HDAC6 VPS45 ARHGAP26 POLR2A THOC2 CBL YWHAE KHSRP FSIP2 LIG3 PPP5C SUGP2 MTHFD1 SUDS3 PKM KIF14 CARS2 EXOSC7 VPS53 | 1.49e-04 | 929 | 160 | 19 | int:PTEN |
| Interaction | HSP90AA1 interactions | HK2 HDAC6 HECTD3 CDKN2AIP NUMA1 HEATR5A ACTN1 THOC2 AHSA1 YWHAE FHAD1 LIMK1 PPP5C ZBED4 MTHFD1 SUDS3 NANS KCNQ4 TLN1 PKM UNC13C ASXL2 SPATS2 | 1.64e-04 | 1263 | 160 | 23 | int:HSP90AA1 |
| Interaction | DISC1 interactions | TPM4 SYNE1 ACTN1 PFKL YWHAE BICD1 PLCD3 CDK5RAP3 PPP5C BRD1 QARS1 RECK | 1.68e-04 | 429 | 160 | 12 | int:DISC1 |
| Interaction | VCL interactions | TPM4 ATP6V1A MYH6 ARHGAP17 ACTN1 THOC2 YWHAE PPP5C TLN1 KIF14 | 1.68e-04 | 305 | 160 | 10 | int:VCL |
| Interaction | CEBPB interactions | TPM4 ATP6V1A COPG1 CDKN2AIP POLR2A TIGD1 NUMA1 SKIL AHSA1 YWHAE DIS3 KHSRP LIG3 PPP5C MTHFD1 NANS FHOD1 TLN1 SF3A3 PKM SAFB2 KIF14 ASXL2 QARS1 LCOR | 1.80e-04 | 1443 | 160 | 25 | int:CEBPB |
| Interaction | PCM1 interactions | CETN1 ENTR1 CNTRL YWHAE BICD1 KIAA1217 KIF14 CEP152 EEA1 SPATS2 BRD1 CCDC40 | 1.87e-04 | 434 | 160 | 12 | int:PCM1 |
| Interaction | SUZ12 interactions | EP400 SYNE1 NUMA1 LMNB2 THOC2 KHSRP LIG3 SUDS3 NCAPD2 SF3A3 PKM SAFB2 KIF14 ASXL2 LCOR | 1.96e-04 | 644 | 160 | 15 | int:SUZ12 |
| Interaction | CENPE interactions | 2.02e-04 | 106 | 160 | 6 | int:CENPE | |
| Interaction | FURIN interactions | 2.07e-04 | 255 | 160 | 9 | int:FURIN | |
| Interaction | KBTBD4 interactions | POLR2A CKAP5 SNAP29 AP2M1 SUGP2 MTHFD1 NCAPD2 TLN2 QARS1 HDLBP | 2.23e-04 | 316 | 160 | 10 | int:KBTBD4 |
| Interaction | VIM interactions | HDAC6 UACA ENTR1 CNTRL ACTN1 THOC2 CBL AHSA1 YWHAE BICD1 PPP5C KIAA1217 KIF14 ASXL2 BRD1 EXOSC7 HDLBP | 2.30e-04 | 804 | 160 | 17 | int:VIM |
| Interaction | HMGN5 interactions | 2.33e-04 | 154 | 160 | 7 | int:HMGN5 | |
| Interaction | IFITM3 interactions | TPM4 ATP6V1A FKBP15 VPS45 SNX17 AIF1L LMNB2 ACTN1 PFKL LIG3 AP2M1 EEA1 QARS1 | 2.36e-04 | 513 | 160 | 13 | int:IFITM3 |
| Interaction | CCDC8 interactions | EP400 POLR2A NUMA1 CKAP5 LMNB2 PFKL YWHAE KHSRP LIG3 SUGP2 MTHFD1 PKM EEA1 QARS1 HDLBP | 2.39e-04 | 656 | 160 | 15 | int:CCDC8 |
| Interaction | TOP3B interactions | TPM4 EP400 ARHGAP26 POLR2A ARHGAP17 ICE1 LMNB2 ACTN1 PFKL THOC2 SLC2A1 ARHGEF10L PLCD3 LIG3 SYNE3 ZBED4 SUGP2 CSAD TLN1 NCAPD2 SAFB2 KIF14 TLN2 QARS1 HDLBP | 2.39e-04 | 1470 | 160 | 25 | int:TOP3B |
| Interaction | FBXW7 interactions | SART3 EP400 UACA COPG1 POLR2A NUMA1 MRPL45 PFKL MAGT1 THOC2 YWHAE DIS3 SUGP2 ARHGEF10 MTHFD1 NANS NCAPD2 THG1L SF3A3 EEA1 QARS1 HDLBP | 2.49e-04 | 1215 | 160 | 22 | int:FBXW7 |
| Interaction | CAPZB interactions | TPM4 FKBP15 MYH11 HDAC6 ABHD18 NELFA ENTR1 NUMA1 ARHGAP17 AIF1L VPS26A AP3B1 CBL YWHAE KHSRP BICD1 KIF14 CEP152 EEA1 QARS1 | 2.51e-04 | 1049 | 160 | 20 | int:CAPZB |
| Interaction | CAVIN3 interactions | 2.53e-04 | 71 | 160 | 5 | int:CAVIN3 | |
| Interaction | CTTN interactions | TPM4 SART3 HDAC6 CKAP5 ARHGAP17 AIF1L CBL NCAPG2 BICD1 PPP5C SYK KIF14 | 2.60e-04 | 450 | 160 | 12 | int:CTTN |
| Interaction | APC interactions | MYH11 SYNE1 ACTN1 NUP58 YWHAE AP2M1 SYNE3 NANS FHOD1 KIF14 RP1 | 2.87e-04 | 389 | 160 | 11 | int:APC |
| Interaction | AGRN interactions | 2.91e-04 | 267 | 160 | 9 | int:AGRN | |
| Interaction | SIRT7 interactions | SART3 COPG1 POLR2A NUMA1 CKAP5 LMNB2 ACTN1 THOC2 DIS3 KHSRP SUGP2 TLN1 NCAPD2 KIF14 USP47 HDLBP | 2.93e-04 | 744 | 160 | 16 | int:SIRT7 |
| Interaction | EEA1 interactions | 3.18e-04 | 162 | 160 | 7 | int:EEA1 | |
| Interaction | GPBP1 interactions | 3.27e-04 | 75 | 160 | 5 | int:GPBP1 | |
| Interaction | TES interactions | 3.31e-04 | 332 | 160 | 10 | int:TES | |
| Interaction | JCAD interactions | 3.39e-04 | 42 | 160 | 4 | int:JCAD | |
| Interaction | TRAF6 interactions | ATP6V1A PACSIN1 ACTN1 CBL SNAP29 MTHFD1 SYK PKM LRP6 ASXL2 FGG USP47 | 3.50e-04 | 465 | 160 | 12 | int:TRAF6 |
| Interaction | CYP1A1 interactions | 3.69e-04 | 77 | 160 | 5 | int:CYP1A1 | |
| Interaction | WHAMMP3 interactions | 3.78e-04 | 119 | 160 | 6 | int:WHAMMP3 | |
| Interaction | PTK2B interactions | 3.78e-04 | 119 | 160 | 6 | int:PTK2B | |
| Interaction | ACTB interactions | TPM4 ATP6V1A MYH11 HDAC6 EP400 POLR2A ARHGAP17 AIF1L CBL YWHAE MAP3K4 KHSRP FSIP2 AP2M1 PPP5C FHOD1 PHACTR3 KIF14 DIXDC1 LCOR | 3.78e-04 | 1083 | 160 | 20 | int:ACTB |
| Interaction | SYT6 interactions | 3.95e-04 | 120 | 160 | 6 | int:SYT6 | |
| Interaction | VPS45 interactions | 3.96e-04 | 168 | 160 | 7 | int:VPS45 | |
| Interaction | CTNNB1 interactions | HDAC6 EP400 UACA POLR2A NUMA1 ACTN1 CBL YWHAE LIG3 AP2M1 MTHFD1 KIAA1217 TLN1 MITF PKM KIF14 LRP6 ASXL2 HDLBP | 4.21e-04 | 1009 | 160 | 19 | int:CTNNB1 |
| Interaction | RAC3 interactions | UACA VPS45 SRPRA LMNB2 YWHAE SLC2A1 SNAP29 AP2M1 MACO1 KIAA1217 FHOD1 KIF14 LRP6 PLCB4 | 4.31e-04 | 619 | 160 | 14 | int:RAC3 |
| Cytoband | 14q24 | 7.10e-06 | 11 | 163 | 3 | 14q24 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.88e-04 | 4 | 102 | 2 | 1252 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | SART3 RBL1 DHRS4L2 CDKN2AIP CKAP5 AGGF1 LMNB2 MND1 NUP58 AP3B1 MELK NCAPG2 ZAP70 KHSRP SNAP29 PPP5C SUGP2 MTHFD1 NANS NCAPD2 THG1L KIF14 CEP152 SPATS2 EXOSC7 ATPAF1 HDLBP | 9.03e-08 | 1363 | 163 | 27 | M45782 |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN | 2.30e-06 | 183 | 163 | 9 | M8178 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 5.97e-06 | 155 | 163 | 8 | M39041 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | SART3 ATP6V1A FKBP15 FGD2 ABHD18 SNX17 ARHGAP17 CBL ADA2 YWHAE SYNE3 SYK ASXL2 MRPL24 | 1.20e-05 | 562 | 163 | 14 | M41008 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGM | HK2 ARHGEF28 HEATR5A MND1 MAGT1 MELK NCAPG2 GPD1L SCN7A CEP152 | 2.39e-05 | 307 | 163 | 10 | M39058 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | RBL1 CKAP5 LMNB2 VPS26A MND1 MELK NCAPG2 PPP5C MTHFD1 FHOD1 NCAPD2 SYK KIF14 CEP152 SPATS2 | 3.05e-05 | 694 | 163 | 15 | M45767 |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN | 3.52e-05 | 198 | 163 | 8 | M3792 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP | 3.78e-05 | 200 | 163 | 8 | M5057 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | TRIM46 UACA RBL1 TIGD1 AIF1L LMNB2 MEAK7 BICD1 GPD1L OLIG3 LIMK1 VCAN NCAPD2 PKM LUZP2 CEP152 SPATS2 | 4.29e-05 | 891 | 163 | 17 | M45033 |
| Coexpression | GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN | 5.66e-05 | 156 | 163 | 7 | M8920 | |
| Coexpression | SEMENZA_HIF1_TARGETS | 7.27e-05 | 36 | 163 | 4 | M12299 | |
| Coexpression | GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 8.07e-05 | 165 | 163 | 7 | M9094 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | RBL1 DTNB DHRS4L2 CNTRL CKAP5 ANKMY1 LMNB2 ACTN1 MND1 NUP58 MELK NCAPG2 MTHFD1 NANS NCAPD2 KIF14 CEP152 | 8.16e-05 | 939 | 163 | 17 | M45768 |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.78e-07 | 188 | 163 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.98e-07 | 189 | 163 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.18e-07 | 190 | 163 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.61e-07 | 192 | 163 | 8 | 27723f4e320e49d4a3daafa2d8d3946ff79fab64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.61e-07 | 192 | 163 | 8 | 0a54c79dcfdeb99e3b512d42b22359618cfd17e9 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-07 | 193 | 163 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.31e-07 | 195 | 163 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.31e-07 | 195 | 163 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.56e-07 | 196 | 163 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.35e-07 | 199 | 163 | 8 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.35e-07 | 199 | 163 | 8 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.35e-07 | 199 | 163 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-07 | 200 | 163 | 8 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.64e-07 | 200 | 163 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 7.64e-07 | 200 | 163 | 8 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 7.64e-07 | 200 | 163 | 8 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.54e-06 | 173 | 163 | 7 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.43e-06 | 179 | 163 | 7 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.43e-06 | 179 | 163 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-06 | 180 | 163 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 182 | 163 | 7 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-7|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.94e-06 | 182 | 163 | 7 | af16334fec2c757b03c84cf252d00e92fa81e4cd | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 5.50e-06 | 185 | 163 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-06 | 185 | 163 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | proximal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.70e-06 | 186 | 163 | 7 | c920dffd24f051b54d8b48f801fffc928d99e135 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.70e-06 | 186 | 163 | 7 | d740aca5dc4240851ba7bc5988c0970d785ad0c2 | |
| ToppCell | proximal-Hematologic-Myeloid_Dendritic_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.70e-06 | 186 | 163 | 7 | 4ca7f6c043874a0c536f75af5ca24c7c66725e54 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-06 | 187 | 163 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-06 | 187 | 163 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.11e-06 | 188 | 163 | 7 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.33e-06 | 189 | 163 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.55e-06 | 190 | 163 | 7 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 6.78e-06 | 191 | 163 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.78e-06 | 191 | 163 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.02e-06 | 192 | 163 | 7 | 026f3e38970bea1e6e8d76a4e2becdfb8484b2ff | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-06 | 126 | 163 | 6 | 54247ce9ee0a4f123f1fb225600a4ec698510a86 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.26e-06 | 193 | 163 | 7 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.51e-06 | 194 | 163 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.51e-06 | 194 | 163 | 7 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.51e-06 | 194 | 163 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | 5'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.76e-06 | 195 | 163 | 7 | 600174e35574fe7c44dd923adcf43686e7b01e39 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.76e-06 | 195 | 163 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.76e-06 | 195 | 163 | 7 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 7.76e-06 | 195 | 163 | 7 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.03e-06 | 196 | 163 | 7 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 196 | 163 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.03e-06 | 196 | 163 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.03e-06 | 196 | 163 | 7 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 8.03e-06 | 196 | 163 | 7 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 8.30e-06 | 197 | 163 | 7 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 197 | 163 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-06 | 197 | 163 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.30e-06 | 197 | 163 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 197 | 163 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-06 | 197 | 163 | 7 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 8.30e-06 | 197 | 163 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-06 | 197 | 163 | 7 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-06 | 197 | 163 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.57e-06 | 198 | 163 | 7 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.57e-06 | 198 | 163 | 7 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.57e-06 | 198 | 163 | 7 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 8.57e-06 | 198 | 163 | 7 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.57e-06 | 198 | 163 | 7 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 8.86e-06 | 199 | 163 | 7 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1-28|World / Primary Cells by Cluster | 8.86e-06 | 199 | 163 | 7 | 787688b68ae5d8768c0a24673ae07ab07616764a | |
| ToppCell | (5)_Dendritic_cell-(52)_cycling_DCs|(5)_Dendritic_cell / shred on Cell_type and subtype | 8.86e-06 | 199 | 163 | 7 | d0ff446a197062b10f37b585f3f8716d6d89e5b7 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 8.86e-06 | 199 | 163 | 7 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div1|World / Primary Cells by Cluster | 8.86e-06 | 199 | 163 | 7 | 72823f26ecabcae1b514b7629cfce010c97b929a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.86e-06 | 199 | 163 | 7 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 8.86e-06 | 199 | 163 | 7 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.86e-06 | 199 | 163 | 7 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.86e-06 | 199 | 163 | 7 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.15e-06 | 200 | 163 | 7 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.15e-06 | 200 | 163 | 7 | dd5b753bb1333fa502b9d3a6d65a53a9882b2451 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 9.15e-06 | 200 | 163 | 7 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.15e-06 | 200 | 163 | 7 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.15e-06 | 200 | 163 | 7 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 157 | 163 | 6 | 4766f7d545bf2d775390589460677519cb92f4d5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-05 | 163 | 163 | 6 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-05 | 169 | 163 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.75e-05 | 169 | 163 | 6 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 169 | 163 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.00e-05 | 171 | 163 | 6 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.27e-05 | 173 | 163 | 6 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 174 | 163 | 6 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.41e-05 | 174 | 163 | 6 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 174 | 163 | 6 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.55e-05 | 175 | 163 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-05 | 176 | 163 | 6 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasmablasts|Liver / Manually curated celltypes from each tissue | 4.85e-05 | 177 | 163 | 6 | 1d88ae316d65ca5fdc736c9da93885b6b40c32bb | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 179 | 163 | 6 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 179 | 163 | 6 | 362c003503190dc272fa89185a83a65e063d7a67 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 179 | 163 | 6 | e0eec8d48868c76c3e879f219357c62ceff1bc76 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 179 | 163 | 6 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 179 | 163 | 6 | 7d2e6bde00a9ab4cb21bd48b140ce205e36f9d77 | |
| Drug | SB 202190; Down 200; 1uM; PC3; HT_HG-U133A | SYNE1 ARHGAP26 SRPRA CBL MEAK7 BICD1 LIG3 PPP5C VCAN ATP6V1D LRP6 PADI2 | 1.74e-08 | 195 | 163 | 12 | 7058_DN |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.71e-06 | 198 | 163 | 10 | 5334_DN | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.05e-05 | 192 | 163 | 9 | 3252_DN | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 1686_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; PC3; HT_HG-U133A | 1.29e-05 | 197 | 163 | 9 | 7304_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.34e-05 | 198 | 163 | 9 | 7016_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; HL60; HG-U133A | 1.39e-05 | 199 | 163 | 9 | 1403_UP | |
| Drug | Gleevec; Down 200; 10uM; MCF7; HG-U133A | 1.39e-05 | 199 | 163 | 9 | 366_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.39e-05 | 199 | 163 | 9 | 4159_UP | |
| Disease | Generalized hypotonia | 6.79e-05 | 15 | 160 | 3 | C1858120 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 8.32e-05 | 16 | 160 | 3 | DOID:0070296 (is_implicated_in) | |
| Disease | JUVENILE MYELOMONOCYTIC LEUKEMIA | 1.74e-04 | 4 | 160 | 2 | 607785 | |
| Disease | Juvenile myelomonocytic leukemia | 1.74e-04 | 4 | 160 | 2 | cv:C0349639 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.94e-04 | 21 | 160 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | plasminogen activator inhibitor 1 measurement | 2.13e-04 | 54 | 160 | 4 | EFO_0004792 | |
| Disease | Myelomonocytic leukemia | 2.89e-04 | 5 | 160 | 2 | C0027019 | |
| Disease | Macrothrombocytopenia | 2.89e-04 | 5 | 160 | 2 | C2751260 | |
| Disease | Bipolar Disorder | TPO SYNE1 PFKL YWHAE FABP7 ARHGEF10 MTHFD1 DIXDC1 BRD1 PRODH | 2.92e-04 | 477 | 160 | 10 | C0005586 |
| Disease | mean platelet volume | TPM4 GLOD5 MYH11 ARID4A POLR2A NUMA1 ANKMY1 ACTN1 MEAK7 YWHAE MSANTD1 ZBED4 TRPM3 SYK BRD1 | 4.59e-04 | 1020 | 160 | 15 | EFO_0004584 |
| Disease | Child Development Disorders, Specific | 5.15e-04 | 29 | 160 | 3 | C0085997 | |
| Disease | Child Development Deviations | 5.15e-04 | 29 | 160 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 5.70e-04 | 30 | 160 | 3 | C0008073 | |
| Disease | Autosomal dominant macrothrombocytopenia | 6.03e-04 | 7 | 160 | 2 | C4304021 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 6.03e-04 | 7 | 160 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | MASA syndrome (implicated_via_orthology) | 6.03e-04 | 7 | 160 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Autistic behavior | 8.01e-04 | 8 | 160 | 2 | C0856975 | |
| Disease | Global developmental delay | 8.10e-04 | 133 | 160 | 5 | C0557874 | |
| Disease | Moderate albuminuria | 9.56e-04 | 80 | 160 | 4 | HP_0012594 | |
| Disease | Combined immunodeficiency | 1.43e-03 | 41 | 160 | 3 | C0494261 | |
| Disease | GM3 ganglioside measurement | 1.56e-03 | 11 | 160 | 2 | EFO_0021451 | |
| Disease | RS-6-hydroxywarfarin measurement | 1.60e-03 | 155 | 160 | 5 | EFO_0803328 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.86e-03 | 12 | 160 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | inositol measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0010504 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 2.55e-03 | 14 | 160 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | eating disorder, bipolar disorder | 2.55e-03 | 14 | 160 | 2 | EFO_0005203, MONDO_0004985 | |
| Disease | QT interval | 2.64e-03 | 534 | 160 | 9 | EFO_0004682 | |
| Disease | corneal endothelial cell measurement | 2.88e-03 | 108 | 160 | 4 | EFO_0010079 | |
| Disease | RASopathy | 2.93e-03 | 15 | 160 | 2 | cv:C5555857 | |
| Disease | Sinus Node Dysfunction (disorder) | 2.93e-03 | 15 | 160 | 2 | C0428908 | |
| Disease | urinary albumin to creatinine ratio | 2.99e-03 | 179 | 160 | 5 | EFO_0007778 | |
| Disease | multiple myeloma | 3.28e-03 | 112 | 160 | 4 | EFO_0001378 | |
| Disease | fourth ventricle volume measurement | 3.34e-03 | 16 | 160 | 2 | EFO_0010303 | |
| Disease | pulse pressure measurement | MYH6 MYH11 ARHGAP26 CNTRL CKAP5 HEATR5A PLCD3 LIG3 LIMK1 TRPM3 KIAA1217 SF3A3 TLN2 NDUFAF6 BRD1 FILIP1L | 3.79e-03 | 1392 | 160 | 16 | EFO_0005763 |
| Disease | atrial fibrillation | 4.25e-03 | 371 | 160 | 7 | EFO_0000275 | |
| Disease | Post-Traumatic Osteoporosis | 4.47e-03 | 61 | 160 | 3 | C0751406 | |
| Disease | Osteoporosis, Senile | 4.47e-03 | 61 | 160 | 3 | C0029459 | |
| Disease | Osteoporosis, Age-Related | 4.47e-03 | 61 | 160 | 3 | C0001787 | |
| Disease | Juvenile Myelomonocytic Leukemia | 4.70e-03 | 19 | 160 | 2 | C0349639 | |
| Disease | Osteoporosis | 4.90e-03 | 63 | 160 | 3 | C0029456 | |
| Disease | wheezing | 5.34e-03 | 65 | 160 | 3 | EFO_0009715 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMKKVAGMDVELTVE | 26 | P62258 | |
| LEMKKMISEVTGGVS | 86 | Q9BQI0 | |
| KEMELLIMTKDSGKV | 356 | Q9UMD9 | |
| LVIDEMQRVKGMTER | 1216 | Q96L91 | |
| IDETIDKLKMMEGRN | 1011 | O95696 | |
| KMRDLMASTVGVVEI | 321 | O15013 | |
| DGLEKTRMAVMRKVS | 256 | Q9HCE6 | |
| MKKGQMEKDIRSDVE | 331 | Q9HA82 | |
| SDVISKKEMAIMIEE | 801 | O94986 | |
| MEISDAMRTLKSEVK | 2151 | Q7Z7A1 | |
| IQTKMEEIGRISIEM | 646 | P12814 | |
| EKKIRIENGMEMTNT | 866 | P29374 | |
| EKAMVTETMTKLRNE | 716 | Q96G01 | |
| VTARMILESKTEKKM | 521 | P13611 | |
| TLTERLLKMKDGVAM | 236 | Q96RT6 | |
| LLKMKDGVAMLEEDV | 241 | Q96RT6 | |
| MKEEGVKLLREAMGI | 136 | O95433 | |
| MEVLGVRNEDTMKCK | 291 | O14862 | |
| GKIEEDSEVLMMIKT | 111 | O60888 | |
| LEKEMEEAKKMISGL | 291 | Q155Q3 | |
| SLRKESLIFMKGVMD | 336 | Q0P651 | |
| MTVRELKEELDLMVG | 116 | Q9BZ19 | |
| EITDSNKGRKMLEKM | 616 | Q8N302 | |
| ALMTKAVVPEMEKRG | 146 | Q9BTZ2 | |
| EMKTVPLTAKEERGM | 976 | Q76L83 | |
| DSAKLDAMKRIVGMI | 56 | O00203 | |
| VNSEKMVIGTMLVKD | 1061 | Q13367 | |
| RILMSKKTEMEIVDG | 231 | O95980 | |
| MVAIKIMDKNTLGSD | 36 | Q14680 | |
| MSEIFRKGMKEELQL | 871 | Q8N1W1 | |
| EKMASKLFEMTGERR | 76 | Q6ZTZ1 | |
| ALMTKAVVPEMEKRG | 146 | Q6PKH6 | |
| EVTKEMKTNAMGLIR | 1451 | Q15058 | |
| TSDMDIGKRKIMCVA | 291 | Q9H0U3 | |
| RTVDEMKGALMEIIQ | 66 | Q9H3P2 | |
| EESRQMMREKKVTIL | 246 | P11166 | |
| SKILGMEVMTFKEDR | 56 | A6NK44 | |
| DIIREKMGIDISVLM | 136 | Q8N335 | |
| MKGSEVTAMLEKGER | 576 | P43405 | |
| EVAMRTVKKSSVMRE | 571 | Q03252 | |
| DEISMMGRVVKVEKQ | 611 | P56696 | |
| VMDKILSMAEGIKVT | 96 | Q9NXV6 | |
| KTKEMLLLTRMAEDV | 256 | Q5CZC0 | |
| MKVEMERGLSKETHA | 491 | P52789 | |
| RELEAEGKKLTMDMK | 511 | Q8N5G2 | |
| MKLMRSEGPDVSVKI | 401 | Q96JN0 | |
| EKRTRMMEIFSETKD | 11 | Q9BWT6 | |
| MTEKMKTDIQRGLVL | 611 | P17858 | |
| AEIMETSIQAMKRKV | 91 | P07202 | |
| KDSVSEKTIGLMRMQ | 101 | Q330K2 | |
| GATEEEKLLSRKMMK | 476 | Q6NT32 | |
| NTEIRMAVSKVADKM | 516 | Q5T1M5 | |
| VDVALDKLKGEMMDL | 51 | P07864 | |
| MIEKIDMTGREGRTK | 1166 | O75581 | |
| RSVETLKEMIKSGMN | 56 | P14618 | |
| KRMAGMKESQISAEI | 356 | Q96CW1 | |
| MKMISATEGPVKARE | 111 | Q6P9B6 | |
| EDLKDMSQMILRTKG | 176 | Q9Y2J8 | |
| SEMKRVTKALDLADM | 631 | P49916 | |
| SIFEMMETGKRVGKV | 251 | Q15024 | |
| MLTSSLEEMKRLVGE | 136 | Q7RTU3 | |
| EEKLAMTREMNSKTE | 166 | Q9BY11 | |
| DAATLKSRKMLEEIM | 106 | P02679 | |
| MEKEALMTELSTVKD | 846 | Q15075 | |
| KDMSMLEERIKRSAK | 1411 | Q14008 | |
| GTRKASLKMDQEREM | 1376 | B1AJZ9 | |
| NELMESEGKTVLSKM | 541 | Q9Y2F5 | |
| LKKVMDAVMSDGNLE | 386 | Q86XA9 | |
| RSIEMMDIVVEKNGE | 456 | Q14721 | |
| TIMEEKSTEQKGMIE | 1956 | Q9H799 | |
| KMMVKIEAETREADG | 2716 | Q8TD57 | |
| LTVMFVDERKTMSEK | 496 | Q4L180 | |
| TEMVRTLERKLEAKM | 296 | Q96C92 | |
| LKEEKGIVLMTAEMD | 246 | Q5TC12 | |
| EKMVTMVSVLEDLIG | 396 | Q96JB5 | |
| TEIRAMKGEIHRMKV | 931 | Q4G0X9 | |
| MIEESGNKRKTMAEK | 1 | O60941 | |
| KDVAVIAESIRMAMG | 296 | Q9NZK5 | |
| KEQLSMEMILKAEEG | 256 | Q9P2S6 | |
| LVEEMKKREGFELVM | 391 | Q9Y600 | |
| ALDRESQMKAMKETV | 196 | Q86TE4 | |
| TRIDVAGMKVRELMD | 366 | Q7Z6J4 | |
| KVQEMTSRLEKMAVE | 1166 | Q9ULL0 | |
| TLFMMKELAGAKVER | 466 | P22681 | |
| MMIRVASKQLEEEDG | 231 | Q9Y678 | |
| VREIKDGKMVMTLTF | 106 | O15540 | |
| RMTTREKKVLEAGMG | 866 | Q9UBN7 | |
| FAVSKDGIEKLLTMM | 726 | Q9Y613 | |
| AEDILTMEVLKSTMK | 311 | Q6T423 | |
| GELTKVRMARQKMSE | 126 | Q15020 | |
| SVRMGKEEEKLMIRG | 2131 | Q92736 | |
| DMRERLGKMVVASSK | 581 | P11586 | |
| EISRMSSKAMLKVQE | 271 | Q9BVL2 | |
| VGVEMMKDRKHIDVT | 281 | Q8N323 | |
| KVLEGSELELAKMTM | 86 | Q14980 | |
| MTVEMKVRFRIKEEE | 331 | P56715 | |
| ISVDTGELMAMKEIR | 1361 | Q9Y6R4 | |
| KGLLEMMEQDAESKT | 111 | Q96KR7 | |
| VQKAKMMLDDIVSRG | 201 | Q92945 | |
| SEGEATLRMKLVMED | 396 | P47897 | |
| KVSMMEKSELVNETR | 151 | Q9UGT4 | |
| SIVMVMGITDVDDKI | 111 | Q9HA77 | |
| ALVRISTSMKNMEKE | 16 | Q7Z4K8 | |
| KKQLEALRSMMEAGE | 471 | Q15147 | |
| IILEEMKEKFSMRSG | 346 | P12757 | |
| VATKIDKVDTVMMGK | 3731 | Q8NF91 | |
| ERMEELKGQMLKFSS | 7391 | Q8NF91 | |
| LQRMEVDSGKKMVFT | 756 | Q6ZMZ3 | |
| MAKVTKEERTFQEIM | 851 | P28749 | |
| IERTERMKKTMASQV | 106 | Q9BRJ2 | |
| RPASMAVMEGDLVKK | 481 | Q68EM7 | |
| LEDGKVTISFMKELM | 181 | P53041 | |
| FKMLDTDGNEMIEKR | 181 | Q8IYU8 | |
| GTRSEVESLMKKMKE | 241 | Q9UNA1 | |
| QRMDVLAKKATEMGV | 361 | O43272 | |
| LAKKATEMGVRLMVD | 366 | O43272 | |
| TMAIREVLKMDTSIK | 636 | Q96PZ0 | |
| GVLERTEKMVDKMDQ | 86 | O95721 | |
| KEILGMQTSEMDRKR | 76 | Q5T5P2 | |
| AELEISGKVMETMKR | 681 | Q5T5P2 | |
| SGKVMETMKRLEDPV | 686 | Q5T5P2 | |
| GDLDVAKRMIRMAKE | 31 | Q9NR45 | |
| MATMKEEFGRIKETL | 851 | P13533 | |
| LKTLQEEVMEAMGIK | 191 | Q96A35 | |
| TERMLKTAVSEKMLK | 326 | Q9Y2L1 | |
| KEEMKKMISEVDREG | 66 | Q12798 | |
| SRKITEAIGIISKMM | 631 | Q15021 | |
| METEHGSKMRKSIEI | 81 | Q86XI2 | |
| DVDRIVGLDQMAKMT | 621 | P35749 | |
| DELMVKKSGGSIRKM | 381 | Q15036 | |
| RVVVKEEMDASIKKM | 256 | Q86XZ4 | |
| LKQGTEKADTEEMMR | 371 | P43403 | |
| EAVDISSKRMMKEVL | 61 | Q96N58 | |
| RKLTMVVLSSEKMDE | 311 | Q8NI27 | |
| VLAVMGQTKEAEKMT | 726 | Q8IUR5 | |
| ESERGMKVIENRAMK | 86 | P67936 | |
| EDKTQTIITAMKERM | 1161 | Q8NB66 | |
| KMGSKLEDILMDDTL | 476 | O75030 | |
| KKVRMNEDGSLSVEM | 311 | Q8IWN7 | |
| LEMIKLSEEGMSKAE | 21 | Q96MW7 | |
| LKKMGLTEDEDVRAM | 51 | Q8N3E9 | |
| LPTEMEGKKMAVTRT | 256 | Q9NWX6 | |
| RMLDGTVKTIMVDDS | 91 | Q9Y490 | |
| FTLGIEKMREILMSE | 936 | Q9HCF6 | |
| MTDRKLTMEQIAEKI | 1221 | P24928 | |
| IIETKMLMGEVMREA | 51 | Q9Y5K8 | |
| DMKTMETAEKLARFV | 781 | Q8IX01 | |
| EVLDGVEKMKSMSQL | 1211 | Q96K76 | |
| KSLSREDMESVLDKM | 331 | P08240 | |
| MEVDGKVESIMKRTA | 296 | P38606 | |
| GMKVLLMDKETTGIV | 21 | Q9NRW7 | |
| RGMERTVVMDKSKGE | 566 | Q14151 | |
| TKIVVKGMTRAEMIL | 726 | Q5VIR6 | |
| MKKKELVTVFRMGSE | 336 | Q7Z4N2 | |
| GMKEMLRKFSTEITL | 276 | Q8N9V2 | |
| SMCEMEREKKGRKVT | 596 | Q9BZF9 | |
| IVLNDGETRKMAEMK | 16 | O75436 | |
| GKEDKLRMMETEIQG | 61 | A6NK53 | |
| KIRMLDGSVKTVMVD | 91 | Q9Y4G6 | |
| MGQDVRMEKVVSEIE | 1586 | Q01118 | |
| VMAKEMLTKKSTLRD | 21 | Q12874 | |
| SIMVSGKLDAVMKAR | 126 | Q00341 | |
| TGDSMEVKPIMTRKL | 171 | Q9H7L9 | |
| TGLMDLAKEMTKEAL | 151 | Q7L8A9 | |
| EIVRLVIDEMGFMKT | 51 | Q6ZT98 | |
| RKVEMLFEETMGIDT | 966 | O75132 | |
| VDSVLVKLLEVMEGM | 641 | Q5T447 | |
| TGEVMVMKELIRFDE | 361 | P53667 |